Jonathan Brett

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Topics

Emergency Department

Systematic Review

Methicillin Resistant Staphylococcus Aureus

Top Venues

British journal of clinical pharmacology

Psychopharmacology

Clinical toxicology (Philadelphia, Pa.)

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Jane Ellen Carland, David J Carland, Jonathan Brett, Sophie Lena Stocker, Darren M Roberts, Richard Osborne Day, Tracey-Lea Laba
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review. British journal of clinical pharmacology (2024)
Rachael Wilkes, Darren M Roberts, Paul Liknaitzky, Jonathan Brett
The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics. Clinical toxicology (Philadelphia, Pa.) 62 (4) (2024)
Rachael Wilkes, Darren M Roberts, Paul Liknaitzky, Jonathan Brett
The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics. Clinical toxicology (Philadelphia, Pa.) 62 (4) (2024)
Marcel Schulz, Matthew James Coleshill, Richard Osborne Day, Daniel F B Wright, Jonathan Brett, Nancy E Briggs, Eindra Aung
Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing. British journal of clinical pharmacology 90 (5) (2024)
Jane Ellen Carland, David J Carland, Jonathan Brett, Sophie Lena Stocker, Darren M Roberts, Richard Osborne Day, Tracey-Lea Laba
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review. British journal of clinical pharmacology 90 (9) (2024)
Marcel Schulz, Matthew James Coleshill, Richard Osborne Day, Daniel F B Wright, Jonathan Brett, Nancy E Briggs, Eindra Aung
Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing. British journal of clinical pharmacology (2024)
Oliver Harris, Krista J Siefried, Angela Lin Chiew, Nazila Jamshidi, Daniel T Chung, Nicholas Moore, Una Nic Ionmhain, Darren M Roberts, Nadine Ezard, Jonathan Brett
Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021. Emergency medicine Australasia : EMA (2024)
Rachael Wilkes, Darren M Roberts, Paul Liknaitzky, Jonathan Brett
The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics. Clinical toxicology (Philadelphia, Pa.) (2024)
Oliver Harris, Krista J Siefried, Angela Lin Chiew, Nazila Jamshidi, Daniel T Chung, Nicholas Moore, Una Nic Ionmhain, Darren M Roberts, Nadine Ezard, Jonathan Brett
Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021. Emergency medicine Australasia : EMA 36 (4) (2024)
Jane Ellen Carland, David J Carland, Jonathan Brett, Sophie Lena Stocker, Darren M Roberts, Richard Osborne Day, Tracey-Lea Laba
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review. British journal of clinical pharmacology 90 (9) (2024)
Jonathan Brett, Malcolm Bjørn Gillies, Nicholas Alan Buckley, Sallie-Anne Pearson, Helga Zoega
Patterns of sub-optimal antipsychotic use and misuse in Australia: What can routinely collected data tell us? British journal of clinical pharmacology (2023)
Jane Ellen Carland, Alexandra E Stacy, Andrea L Schaffer, Richard Osborne Day, Jonathan Brett, Stephanie E Reuter, Sophie Lena Stocker
Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin. British journal of clinical pharmacology (2023)
Jonathan Brett, Dilara Bahceci, Wendy Lipworth, Paul Liknaitzky, Richard Osborne Day, Anthony Rodgers
Can old drugs learn new tricks? Achieving registration and public subsidy listing for off-patent medicines with novel therapeutic applications. Internal medicine journal (2023)
Jane Ellen Carland, Alexandra E Stacy, Andrea L Schaffer, Richard Osborne Day, Jonathan Brett, Stephanie E Reuter, Sophie Lena Stocker
Blood, dose recommendation reports and phone calls - Experiences of a Therapeutic Drug Monitoring Advisory Service for vancomycin. British journal of clinical pharmacology (2023)
Claudia Bruno, Helga Zoega, Malcolm Bjørn Gillies, Alys Havard, David Coghill, Sallie-Anne Pearson, Jonathan Brett
Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis. The Australian and New Zealand journal of psychiatry (2023)
Bridin Patricia Murnion, Andrea L Schaffer, Rose Cairns, Jonathan Brett
Gabapentinoids: repeating mistakes of the past? Addiction (Abingdon, England) 117 (12) (2022)
Robert Page, Amy Healey, Krista J Siefried, Mary Ellen Harrod, Erica Franklin, Amy Peacock, Monica J Barratt, Jonathan Brett
Barriers to help-seeking among music festival attendees in New South Wales, Australia. Drug and alcohol review 41 (6) (2022)
Krista J Siefried, Georgia Freeman, Darren M Roberts, Rhiannon Lindsey, Craig Rodgers, Nadine Ezard, Jonathan Brett
Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review. Psychopharmacology 240 (1) (2022)
Krista J Siefried, Georgia Freeman, Darren M Roberts, Rhiannon Lindsey, Craig Rodgers, Nadine Ezard, Jonathan Brett
Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review. Psychopharmacology 240 (1) (2022)
Krista J Siefried, Georgia Freeman, Darren M Roberts, Rhiannon Lindsey, Craig Rodgers, Nadine Ezard, Jonathan Brett
Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review. Psychopharmacology (2022)
Krista J Siefried, Georgia Freeman, Darren M Roberts, Rhiannon Lindsey, Craig Rodgers, Nadine Ezard, Jonathan Brett
Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review. Psychopharmacology 240 (1) (2022)
Krista J Siefried, Georgia Freeman, Darren M Roberts, Rhiannon Lindsey, Craig Rodgers, Nadine Ezard, Jonathan Brett
Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review. Psychopharmacology 240 (1) (2022)
Andrea L Schaffer, Joel Chia, Jonathan Brett, Sallie-Anne Pearson, Michael O Falster
A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia. Pharmacotherapy 42 (11) (2022)
Krista J Siefried, Georgia Freeman, Darren M Roberts, Rhiannon Lindsey, Craig Rodgers, Nadine Ezard, Jonathan Brett
Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review. Psychopharmacology 240 (1) (2022)
Bianca Varney, Helga Zoega, Malcolm Bjørn Gillies, Jonathan Brett, Sallie-Anne Pearson, Alys Havard
Prescription opioid use in Australian women of reproductive age: Implications for unplanned pregnancies. British journal of clinical pharmacology (2021)
Jonathan Brett, Krista J Siefried, Amy Healey, Mary Ellen Harrod, Erica Franklin, Monica J Barratt, Jem Masters, Lynn Nguyen, Santosh Adiraju, Cobus Gerber
Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019-2020. Clinical toxicology (Philadelphia, Pa.) (2021)
Amy Healey, Krista J Siefried, Mary Ellen Harrod, Erica Franklin, Amy Peacock, Monica J Barratt, Jonathan Brett
Correlates of higher-risk drug-related behaviours at music festivals in New South Wales, Australia. Drug and alcohol review (2021)
Tricia Chiu, Jonathan Brett, Sallie-Anne Pearson, Andrea L Schaffer
Patterns of pregabalin initiation and discontinuation after its subsidy in Australia. British journal of clinical pharmacology 86 (9) (2020)
Claire E Wylie, Benjamin Daniels, Jonathan Brett, Sallie-Anne Pearson, Nicholas Alan Buckley
A national study on prescribed medicine use in Australia on a typical day. Pharmacoepidemiology and drug safety 29 (9) (2020)
Jonathan Brett, Sallie-Anne Pearson, Benjamin Daniels, Claire E Wylie, Nicholas Alan Buckley
A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy. British journal of clinical pharmacology 87 (3) (2020)
Maurizio Stefani, Darren M Roberts, Jonathan Brett
High-dose insulin euglycemic therapy to treat cardiomyopathy associated with massive venlafaxine overdose. Clinical toxicology (Philadelphia, Pa.) 58 (4) (2019)
Jonathan Brett, Claire E Wylie, Jacques Raubenheimer, Geoffrey K Isbister, Nick A Buckley
The relative lethal toxicity of pharmaceutical and illicit substances: A 16-year study of the Greater Newcastle Hunter Area, Australia. British journal of clinical pharmacology 85 (9) (2019)
Natasa Gisev, Jonathan Brett, Amy Peacock
Extra-medical use of antipsychotics: what can be learnt from experiences with other prescription medicines? Addiction (Abingdon, England) 115 (7) (2019)
Jonathan Brett, Claire E Wylie, Jared A Brown
A case of significant hypotension following a human ingestion of veterinary pimobendan. Clinical toxicology (Philadelphia, Pa.) 58 (2) (2019)
Kelsey Chalmers, Tim Badgery-Parker, Sallie-Anne Pearson, Jonathan Brett, Ian A Scott, Adam G Elshaug
Developing indicators for measuring low-value care: mapping Choosing Wisely recommendations to hospital data. BMC research notes 11 (1) (2018)
Jonathan Brett, Helga Zoega, Nicholas A Buckley, Benjamin J Daniels, Adam G Elshaug, Sallie-Anne Pearson
Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia. BMC health services research 18 (1) (2018)
Jonathan Brett, Andrea L Schaffer, Timothy Dobbins, Nicholas A Buckley, Sallie-Anne Pearson
The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis. Pharmacoepidemiology and drug safety 27 (4) (2018)
Jonathan Brett, Donovan T Maust, Zach Bouck, Rosalinda V Ignacio, Graham Mecredy, Eve A Kerr, Sacha Bhatia, Adam G Elshaug, Sallie A Pearson
Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016. Journal of the American Geriatrics Society 66 (6) (2018)
Jonathan Brett, Benjamin Daniels, Emily A Karanges, Nicholas A Buckley, Carl Schneider, Atheer Nassir, Andrew J McLachlan, Sallie-Anne Pearson
Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study. British journal of clinical pharmacology 83 (11) (2017)
Emily Aspasia Karanges, Nicholas A Buckley, Jonathan Brett, Bianca Blanch, Melisa Litchfield, Louisa Degenhardt, Sallie-Anne Pearson
Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics. Pharmacoepidemiology and drug safety 27 (5) (2017)